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Closing the Sendai virus C protein open reading frames (rSeV-ΔC virus) results in the production of virus particles with highly reduced
infectivity. Besides, the Sendai virus C proteins interact with Alix/AIP1 and Alix suppression negatively affects Sendai virus like particle (VLP)
budding. Similarly, the Sendai virus M protein has been shown to interact with Alix. On this basis, it has been suggested that Sendai virus budding
involves recruitment of the multivesicular body formation machinery. We follow, here, the production of SeV particles upon regular virus
infection. We find that neither Alix suppression nor dominant negative-VPS4A expression, applied separately or in combination, affects physical
or infectious virion production. This contrasts with the observed decrease of SV5 virion production upon dominant negative-VPS4A expression.
Finally, we show that suppression of more than 70% of a GFP/C protein in the background of a rSeV-ΔC virus infection has no effect either on
SeV particle production or on virus particle infectivity. Our results contrast with what has been published before. Possible explanations for this
discrepancy are discussed.
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Enveloped viruses acquire their lipid by-layer by budding
from cellular membranes. The virus particle components first
assemble at these membranes in an orderly way before the
modified portion of the membrane forms a bud that eventually
pinches off. This process has been recognized similar to that of
cellular vesicles budding into or out of multivesicular bodies
(MVBs) owing to the fact that cellular partners involved in this
vesiculation are recruited by proteins of several enveloped
viruses. Retroviral Gag proteins and the matrix proteins of some
negative strand RNA viruses have been shown to interact with
these cellular partners via domains called late domains (Freed,
2002; Morita and Sundquist, 2004).⁎ Corresponding author. Fax: +41 22 379 5702.
E-mail address: laurent.roux@medecine.unige.ch (L. Roux).
0042-6822/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2007.03.039Different types of late domains have been characterized. P(T/
S)AP, PPxY and YP(x)nL late domains have been identified in
the p6, the p2b and the p9 regions of respectively the human
immunodeficiency virus type 1 (HIV-1), the Rous sarcoma virus
(RSV) and the equine infectious anemia virus (EIAV) Gag
proteins (Gottlinger et al., 1991; Huang et al., 1995; Wills et al.,
1994; Xiang et al., 1996; Puffer et al., 1997). As for the
negative-strand RNAviruses, the same P(T/S)AP and PPxY late
domain sequences have been identified in the matrix M proteins
of, respectively, the vesicular stomatitis virus (VSV), a Rhab-
dovirus, and the Ebola virus, a Filovirus, and have been shown
to be relevant for their respective budding (Craven et al., 1999;
Harty et al., 1999, 2000; Jayakar et al., 2000; Licata et al., 2003;
Martin-Serrano et al., 2001, 2004). For the Paramyxovirus
SV5, the matrix protein lacks these previously defined late
domains, but rather contains a new motif (FPIV), of which the
proline was found critical for its function (Schmitt et al., 2005).
Interestingly, when this proline was mutated, leading to a
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compensatory mutation occurred rapidly, which restored
budding. This mutation consisted in a new proline residue
elsewhere in the matrix protein, recreating the more general
motif ϕ-P-x-V.
These late domain motifs are likely to function by recruiting
the cellular machinery involved in MVB formation via
interactions with cellular partners which are part of this
machinery (Slagsvold et al., 2006). P(T/S)AP late domain
mediates binding to TSG101 (Garrus et al., 2001; Martin-
Serrano et al., 2001; VerPlank et al., 2001) and YP(x)nL appears
to bind to AIP1/Alix (Martin-Serrano et al., 2003a,2003b;
Strack et al., 2003; Vincent et al., 2003; von Schwedler et al.,
2003). For PPxY, the cellular partners relevant to budding have
yet to be unequivocally identified, although PPxY motif has
been shown to interact with Nedd4-related E3 ubiquitin ligases
(Harty et al., 1999; Kikonyogo et al., 2001; Timmins et al.,
2003), an interaction that may, in turn, allow recruitment of
proteins involved in MVB formation (Strack et al., 2003). The
cellular partner of the SV5 ϕ-P-x-V motif has not been
determined. Regardless of the nature of the cellular partner, the
cellular machinery involved in MVB formation appears to
require the activity of the VPS4A ATPase. VPS4A is required to
recycle this machinery allowing multiple rounds of vesicle
formation and its inactivation results in the blocking of the
vesiculation (Babst et al., 1997, 1998; Bishop and Woodman,
2001; Katzmann et al., 2002). Dominant negative versions of
VPS4A (DN-VPS4A) are available whose overexpression
blocks budding of Retroviruses, Filoviruses and Paramyxo-
viruses (Garrus et al., 2001; Licata et al., 2003; Martin-Serrano
et al., 2003a,2003b; Shehu-Xhilaga et al., 2004; von Schwedler
et al., 2003; Schmitt et al., 2005), with the exception of VSV.
For this latter, despite the clear demonstration of the presence of
a functional late domain PPPY in the matrix protein (Irie et al.,
2004a; Craven et al., 1999), despite the fact that this domain
could be exchanged with that of the Ebola VP40 protein (Irie et
al., 2005), DN-VPS4A overexpression had no deleterious effect
on its budding (Irie et al., 2004b).
For Sendai virus (SeV), another member of the Paramyxo-
virus family, the viral protein claimed to recruit the MVB
sorting machinery has first been an accessory protein named C.
The C protein is in fact part of an array of four C polypeptides
encoded by the viral P mRNA in the +1 open reading frame
(Curran and Kolakofsky, 1990). The C proteins have been
shown to regulate the activity of the viral RNA polymerase
(Cadd et al., 1996; Latorre et al., 1998; Tapparel et al., 1997).
Moreover, they have been found to counteract the interferon-
mediated antiviral innate response (Takeuchi et al., 2001; Gotoh
et al., 1999; Garcin et al., 1999, 2000, 2001, 2002, 2004). C
protein knock out viruses (rSeV-ΔC) were found highly
attenuated in mice and produced virus particles with highly
decreased infectivity to particle ratios (Latorre et al., 1998;
Kurotani et al., 1998). Moreover, C expression was shown to
moderately facilitate (2.5-folds) SeV M shedding, when M was
expressed along with the other viral proteins N, F and HN.
Under these conditions, however, C expression had no notice-
able effect on the production of the three other proteins(Sugahara et al., 2004). The C protein was further shown to
interact with AIP1/Alix (Sakaguchi et al., 2005; Irie et al.,
2006), and Alix overexpression resulted in a 4-fold increase of
M in virus particles and its suppression lowered this M amount
by less than 3-folds (Sakaguchi et al., 2005). This contrasted
with the absence of M budding enhancement in virus like
particles (VLP) after Alix overexpression (Irie et al., 2007).
Overexpression of a DN-VPS4A was shown to lower the SeV
infectivity produced in the cell medium by about 4-folds when
compared to the condition of wt-VPS4A expression (Sakaguchi
et al., 2005). Curiously, when the same authors performed SeV
virus like particle (VLP) budding assays by expressing M, N, F,
HN and C, they found that overexpressing VPS4A-wt, this time,
caused a strong suppression of VLP release, a release that was
rather restored by DN-VPS4A expression. These various
observations, despite some inconsistency, led to propose that
the C proteins participate in virus particle production by
recruiting the MVB formation machinery.
On the other hand, SeV M protein has clearly been identified
as central for virus particle production without which no
particles are formed (Sakaguchi et al., 1999; Takimoto et al.,
2001; Sugahara et al., 2004; Mottet-Osman et al., 2007 and
unpublished results). Very recently, a YLDL domain was
identified which is claimed to promote a specific M–Alix
interaction, and suppression of Alix was shown to result in a 10-
fold M shedding decrease (Irie et al., 2007). YLDL, however,
could not be replaced by other late domains and, when M was
co-expressed with N, HN and F, the 2-fold increase in M
shedding, promoted by the C expression, was not observed for
the other three proteins.
In the end, the observations concerning SeV budding in
relation with the MVB machinery are overall difficult to
interpret. In this study, we have followed the effects that
suppression of AIP1/Alix and DN-VPS4A overexpression had
on virus particle budding during the course of a regular SeV
infection. Unexpectedly, we were not able to demonstrate a
significant inhibitory effect on physical or infectious particle
production under either condition. Even a coupling of the two
conditions did not lead to a more relevant effect. We were
equally not successful in demonstrating the effect of Alix
suppression and DN-VPS4A expression on M shedding when
the protein was expressed by itself in transfected cells. In the
end, we measured virus particle production after suppression of
a C protein expressed from an otherwise delta C protein
recombinant SeV (rSeV-ΔC-GFP/C). Here again, suppression
of C was not followed by a decrease in virus particle production.
The involvement of the MVB machinery in SeV particle
budding is discussed in view of these data.
Results
Suppression of AIP1/Alix during the course of a viral infection
In a first series of experiments, suppression of Alix was
achieved by transfection of cells with siRNAs. Different cell
types were used (HeLa, 293T) and were transfected with the
appropriate siRNAs 48 h prior to SeV infection. Virus
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measures of the physical particles produced or by titration of
the viral infectivity in the supernatant. Although Alix
suppression, monitored by Western blotting, was effective,
under no conditions its suppression had an effect on virus
particle production estimated by the measure of the N protein
production (see Fig. 1, for an example).
As these experiments are dependent on fluctuating
transfection efficiencies (varying between 30–70%), the effect
of suppression of Alix on virus particle budding could have
been masked by the viral production of the non-transfected but
infected cells. In order to make up for this problem, cell lines
were produced that constitutively expressed α-Alix-siRNAs in
all the cells (>95%). These were generated by transduction of
the cells with a lentivirus vector constitutively expressing the
α-Alix-siRNAs along with the GFP protein. This latter marker
served the purpose of selecting the transduced cells, so to
achieve a culture in which all the cells were actually
expressing the siRNAs. Two cell lines, FTGH and 293T,
were prepared in this way with their matched control, i.e. cell
lines transduced with a vector expressing GFP only.Fig. 1. Cellular Alix suppression by siRNA transfection and SeV particle
production. HeLa cells in 35 mm-diameter dishes were transfected with 20 μM
of anti-Alix siRNA, and 48 h later, the cells were infected with SeV (m.o.i. of 2).
Forty hours later, culture medium and cells were harvested. Cell extracts were
prepared and the virus particles present in the supernatants were isolated as
described in Materials and methods. (A) Forty micrograms of total proteins
(measured by Bradford assay) of the cell extracts or about 1/6th (adjusted to the
total amount of proteins in cell extracts) of the virus particles (VP) were
analyzed by Western blotting using α-Alix, α-SeV-N antibodies. (B) The bands
of Alix in cell extracts were quantified and expressed relative to the values
obtained in control cells (minus siRNA) normalized to 1. (C) The bands of N
proteins in cell extracts and virus particles were quantified and expressed
relative to the values obtained in control cells normalized to 1. Budding
efficiency was estimated by following the N protein fate (ratio NVP/NIC) and was
calculated by dividing the relative N signal obtained in VP by the relative signal
obtained in cell extracts. For (B) and (C), bars indicate standard deviation from
the mean (3 experiments).FTGH or 293T cells expressing α-Alix-siRNAs were then
infected or mock infected with SeV and the cells and the
supernatants were collected. The amounts of Alix, of actin
and of the viral proteins HN, N and M present in the cell
extracts were monitored by Western blots. The virus particles
present in the cell supernatants were collected and similarly
analyzed for their content in the same viral proteins. The
results, presented in Fig. 2, show that the suppression of the
Alix protein was efficient in each sample derived from cells
expressing the α-Alix-siRNAs (+) (Fig. 2E). Conditions of
Alix suppression had no effect on the amounts of viral
proteins present in the cell extracts, indicating that the extent
of the infection was similar, although a general increase was
observed between 16 and 24 h pi (for the FTGH-cells). As for
the virus particle production (Fig. 2B, SeV-VP), here again,
no difference could be observed between the ±siRNA
conditions (Figs. 2C and D, for quantification).
A fraction of the cell supernatants was used to measure the
infectious titers of the produced particles (Table 1). The titers
obtained varied somehow from experiment to experiment, as
did the comparison between the ±Alix conditions. A 2-fold
decrease could be observed in some experiments (Exp 1, Exp
5, 48 h pi), but this was not consistent. For instance, no
difference could be noted in Exp 2 and 4 (16 h and 48 h pi)
and cases of increase virus production were also observed
(Exp 2 and 3, 24 h pi). Matching these results with those
obtained by Western blots indicates that suppression of Alix
in both cell types had no significant effect on virus particle
production.
Expression of VPS4A dominant negative proteins and SeV
particle production
Next, the effect of neutralizing the action of VPS4A by
overexpression of two dominant negative (DN) versions
(E228Q and K173Q) was analyzed. 293T cells were
transfected with plasmid expressing the wt or the mutant
versions of the protein prior to infection with SeV. Forty
hours following infection, the cells and cell supernatants
were collected and analyzed as above. In this experiment,
the VPS4A proteins are fused with the GFP protein so that
the efficiency of transfection was readily estimated by the
amount of fluorescent cells. In the experiment presented in
Fig. 3 (and others, not shown), the transfection efficiency
was close to 65%. Western blots show the expression of the
VPS4A proteins (Fig. 3A, VPS4A). Their expression did not
alter the amounts of viral proteins monitored in the cells
extracts (Fig. 3A, SeV-IC). In Fig. 3B, the amounts of
proteins in the virus particles produced are presented.
Neither overexpression of VPS4A (wt lane), nor expression
of the DN-VPS4A had a marked effect on virus production
(Fig. 3C for quantification). This lack of effect was
corroborated by the titrations of the virus particles presented
in Table 2. In this case the results were very steady. If
anything, a slight increase in infectious virus was observed
when the DN mutant K173Q was present. This variation,
however, remained nonsignificant.
Fig. 2. Cellular Alix protein suppression by siRNA expression and SeV particle production. FTGH-ctrl, FTGH-α-Alix-siRNA, 293T-ctrl or 293T-α-Alix-siRNA cell
lines in 35 mm-diameter dishes were infected with SeV (m.o.i. of 2). Culture medium and cells were harvested at the indicated time post infection (hours pi). Cell
extracts were prepared and the virus particles present in the supernatants were isolated as described in Materials and methods. (A) Forty micrograms of total proteins
(measured by Bradford assay) of the cell extracts or (B) about 1/6th (adjusted to the total amount of proteins in cell extracts) of the virus particles (VP) were analyzed
by Western blotting using α-Alix, α-actin, α-SeV-HN, α-SeV-N and α-SeV-M antibodies. (C) The bands of SeV-HN,-N and-M proteins in FTGH cell extracts and
virus particles were quantified and expressed relative to the values obtained in control cells normalized to 1. Budding efficiency (ratio VP/IC) as in Fig. 1C. Standard
deviations from the mean are indicated (3 experiments). (D) As in C but with 293T cells (3 experiments). (E) The bands of Alix in FTGH or 293T cell extracts were
quantified and expressed relative to the values obtained in control cells normalized to 1 (6 experiments). Standard deviations, as in (C) and (D).
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Assuming that Alix suppression or DN-VPS4A expression
effects could be masked because a too high fraction of cells
would not be affected by one or the other condition, weTable 1
Cellular Alix protein suppression and SeV infectious particles production
Cells α-Alix-siRNA
expression
pfu at 16
hours pi
pfu at 24
hours pi
pfu at 48
hours pi
Exp1 FTGH – 3.9×105 nd nd
+ 1.4×105 nd nd
Exp2 – 4.5×105 2.5×106 nd
+ 4.5×105 3.4×106 nd
Exp3 – nd 1.2×106 nd
+ nd 2.1×106 nd
Exp4 293T – nd nd 2.4×106
+ nd nd 2.1×106
Exp5 – nd 5.7×105 9.8×106
+ nd 3.5×105 4.1×106
FTGH-ctrl, FTGH-α-AIP1-siRNA, 293T-ctrl or 293T-α-Alix-siRNA cell lines
were infected with SeV (m.o.i. of 2). Culture mediums were harvested at the
indicated time post infection and viral titers were determined as described in
Materials and methods.reasoned that the combination of the two conditions could
complement for each other possible defection. The 293T cells
expressing the α-Alix-siRNAs and their matched control were
therefore transfected with the plasmids expressing the VPS4A
protein and its DN versions in a protocol similar to that
described in Fig. 3. The results shown in Fig. 4 are very clear in
that they do not show any sign of additive effects of the two
combined conditions, this in situations where Alix and the
VPS4A proteins were, respectively, effectively suppressed and
efficiently expressed. Once more, titration of the infectious
particles in the supernatants came to corroborate this conclusion
(Table 3).
Budding of SeV M in relation to Alix and VPS4A functions
The main purpose of this study was to follow the production
of the SeV virus particle in the context of an infection. We felt,
however, disturbing that differences in SeV-virion production
could not be observed under conditions previously reported to
negatively affect SeV-virus like particle (VLP) production.
Following the recent report that the SeV-M budding was
affected by Alix suppression (Irie et al., 2007), we decided to
drift from our original goal. We performed the analysis of M
Fig. 3. Cellular VPS4A protein expression and SeV particle budding. 293T cells
in 35 mm-diameter dishes were transfected with 2 μg of pVPS4A-wt, pVPS4A-
E228Q or pVPS4A-K173Q using the FuGENE 6 transfection reagent (Roche).
Six hours after transfection, cells were infected with SeV (m.o.i. of 2). Culture
medium and cells were harvested at 40 h pi. Cell extracts were prepared and the
virus particles present in the supernatants were isolated as described in Materials
and methods. (A) Forty micrograms of total proteins (measured by Bradford
assay) of cell extracts or (B) about 1/6th (adjusted to the total amount of proteins
in cell extracts) of the virus particles (VP) were analyzed by Western blotting
using anti-GFP, anti-SeV HN, anti-SeV N and anti-SeV M antibodies. (C) The
bands of SeV-HN, -N and -M proteins in cell extracts and virus particles were
quantified and expressed relative to the values obtained in control conditions
(absence of transfected VPS4A) normalized to 1. Budding efficiency (ratio VP/
IC) as in Fig. 1C. Standard deviations from the mean are indicated (4
experiments).
Table 2
Cellular VPS4A proteins expression and SeV infectious particles production
SeV VPS4A pfu at 40 h pi
Exp1 +wt 1.0×107
+E228Q 1.5×107
+K173Q 1.8×107
Exp2 +wt 7.7×107
+E228Q 7.7×107
+K173Q 9.0×107
Exp3 +wt 1.2×107
+E228Q 1.4×107
+K173Q 1.5×107
Exp4 No 4.6×107
+wt 2.2×107
+E228Q 2.5×107
+K173Q 1.8×107
293T cells in 35 mm-diameter dishes were transfected with 2 μg of pVPS4A-wt,
pVPS4A-E228Q or pVPS4A-K173Q. Six hours after transfection, cells were
infected with SeV (m.o.i. of 2). Viral titers, as in Table 1.
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VPS4A, as well as in conditions of Alix suppression. As shown
in Fig. 5, neither condition could exert any significant influence
on the amount of M shed into the medium in the form that
sediments through a 25% glycerol cushion as virus particles do.In part A (VPS4A) and in part B (Alix suppression), the ratios of
intracellular to extracellular M (HA-MIC/HA-MOUT) remain
unchanged. It is noteworthy that the M protein tagged at the N-
terminus with an HA epitope was used rather than the wild type
M. However, this is unlikely to explain the lack of effect of
these conditions, since the HA-M was previously shown to
behave exactly like the wild type protein in the course of an
infection (Mottet et al., 1996). In the end, the study of SeV
budding, reduced to that of its main effector, did not lead more
than that of its complete set of structural proteins to conclude in
the involvement of MVB machinery partners.
Expression of VPS4A dominant negative proteins reduces SV5
particle production
At this point, it became important to check whether the
conditions of our experiments were sensitive enough to
demonstrate an effect of the applied conditions on virus particle
budding. We therefore attempted to reproduce the data obtained
in the study of the SV5 virus, a Paramyxovirus, genus Rubu-
lavirus, for which it was reported that the budding of virions
from infected cells was affected by the expression of the DN-
VPS4A proteins (Schmitt et al., 2005). SV5 budding (Fig. 6A)
was then followed in parallel with that of SeV (Fig. 6B). In Figs.
6A and B (VPS4A), the extent of VPS4A protein expression is
shown. Below, the extent of the SV5 or SeV infections is
estimated after immune-precipitation of two viral proteins, HN
and N (cell extracts). The lower panel shows that the viral
particles recovered in the supernatants. In the case of SV5, the
amount of virus particles (VP) was clearly diminished in co-
expression with the two DN-VPS4A. Interestingly, the decrease
in virus particle production was accompanied, in the infected
cells, by a surplus of HN, likely reflecting its accumulation due
to restricted virus particle production. Also remarkable is the
presence of VPS4A in SV5 virus particles (identified by
Western blotting, not shown). None of these features is seen in
the case of SeV (Fig. 6B). The amount of intracellular HN is
steady (cell extracts), as are the amounts of SeV particle
Fig. 4. Combined effect of Alix suppression and VPS4A proteins expression
on SeV particle budding. 293T-ctrl and 293T-α-Alix-siRNA cells in 35 mm-
diameter dishes were transfected with 2 μg of pVPS4A-wt, pVPS4A-E228Q
or pVPS4A-K173Q. Six hours post transfection, cells were infected with
SeV (m.o.i. of 2). Culture medium and cells were harvested at 40 h pi. Cell
extracts were prepared and the virus particles present in the supernatants
were isolated as described in Materials and methods. (A) Forty micrograms
of total proteins in cell extracts or (B) about 1/6th (adjusted to the total
amount of proteins in cell extracts) of the virus particles (VP) were analyzed
by Western blotting using anti-GFP, anti-SeV HN, anti-SeV N and anti-SeV
M antibodies. (C) The bands of SeV-HN, -N and -M proteins in cell extracts
and virus particles were quantified and expressed relative to the values
obtained in control conditions (293T-ctrl cell lines in absence of transfected
VPS4A) normalized to 1. Budding efficiency (ratio VP/IC), as in Fig. 1C.
Standard deviations from the mean are indicated (2 experiments).
Table 3
Combination of Alix suppression and VPS4A proteins expression on SeV
infectious particles production
VPS4A 293T-ctrl 293T-α-Alix-siRNA
+wt 5.20±0.53×106 3.73±0.18×106
+E228Q 5.25±0.25×106 4.27±0.29×106
+K173Q 5.40±0.40×106 4.37±0.42×106
293T-ctrl and 293T-α-Alix-siRNA cells in 35 mm-diameter dishes were
transfected with 2 μg of pVPS4A-wt, pVPS4A-E228Q or pVPS4A-K173Q.
Six hours after transfection, cells were infected with SeVat an m.o.i. of 2. Viral
titers, as in Table 1. The results are presented as the mean of 2 experiments with
standard deviation from the mean.
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ison, the proteins were radiolabeled so that the evaluation of
their amounts in virus particles was direct. The same decrease in
SV5 proteins in virus particle could be observed byWestern blot
analysis (not shown). It is also noteworthy that radio-isotope
labeling conditions were also performed for the experiments
presented in Figs. 2–4 and, as in the present case, these
conditions never led to the observation of a SeV budding
decrease (not shown). Production of SV5 infectious particleswas also estimated by titration and a minimum of a 3-fold
decrease in virus titer could be observed (Table 4). In the end,
our ability to reproduce the results obtained for SV5 validates
our observations concerning SeV.
SeV particle production in the context of the C protein
suppression
The involvement of the cellular MVB machinery in SeV
particle production has been called upon after the observation
that (1) recombinant SeVs, in which the C protein ORFs had
been closed (rSeV-ΔCs), were highly attenuated and produced
virus particles with significant lower infectivity (Kurotani et al.,
1998; Latorre et al., 1998), and (2) the SeV-C and M proteins
were shown to interact with Alix (Sakaguchi et al., 2005; Irie et
al., 2007). Recombinant SeV-ΔCs are debilitated viruses that
were rescued after several infection cycles in embryonated eggs
(Latorre et al., 1998; Kurotani et al., 1998). This procedure gave
potential room for selection of compensatory mutations. In that
respect, the expression of a C protein (fused to the green
fluorescent protein; GFP/C) from a supplementary transcription
unit located between the F and the M genes of SeV-ΔCs
(creating rSeV-ΔCs-GFP/C), was able to fully complement the
ablation of the C proteins (Machiko Nishio, Daniel Kolakofsky,
unpublished, University of Geneva). We rationalized, then, that
suppression of the GFP/C protein in rSeV-ΔCs-GFP/C infection
represented a more direct way to realize and analyze the ΔC
protein conditions. To suppress the GFP/C protein, we made use
of an A549 cell line constitutively expressing an siRNA
directed against the GFP mRNA sequence (α-GFP-siRNA).
This cell line, A549-LV-siGFP, was found very efficient in
suppressing the M protein when its messenger carried the GFP-
siRNA target sequence in its 3′ untranslated region, a
modification introduced in a SeV recombinant called rSeV-M-
gfpt (Mottet-Osman et al., 2007).
A549-LV-siGFP and its matched control cell line were then
infected with rSeV-ΔCs-GFP/C. Both cell lines were also
infected with rSeV-M-gfpt as a control to evaluate the potency
of the α-GFP-siRNAs. From 16 h pi, the cells were
metabolically radiolabeled and at 40 h pi, the cells and the
supernatants were collected. The intracellular P, GFP/C, M and
C proteins were detected by Western blots (Fig. 7A). In parallel
the 35S-labeled P, HN, F0 and N proteins were recovered by
immune-precipitation from the cell extracts (Fig. 7B) and the
Fig. 5. Effects of VPS4A proteins expression and Alix suppression on SeV-M shedding. (A) 293T cells in 35 mm-diameter dishes were first transfected with 2 μg of
pVPS4A-wt, pVPS4A-E228Q or pVS4A-K173Q, and 16 h later, transfected with 2 μg of pEBS-HA-M. Culture medium and cells were harvested at 40 hours post
transfection. Cell extracts were prepared and the M present in the supernatants was isolated as described in Materials and methods. Forty micrograms of total proteins
in cell extracts or about 1/6th of VP (adjusted to the total amount of proteins in cell extracts) were analyzed byWestern blotting using anti-GFP and anti-HA antibodies.
(B) 293T-ctrl and 293T-α-Alix-siRNA cells in 35 mm-diameter dishes were transfected with pEBS-HA-M (from 0 to 3 μg) as in (A). (C) The bands of SeV-HA-M in
cell extracts and supernatants were quantified and expressed relative to the values obtained in control conditions (no VPS4A transfection) normalized to 1. Budding
efficiency (ratio MOUT/MIC) was calculated by dividing the relative signal obtained in supernatants by the relative signal obtained in cell extracts. Standard deviations
from the mean are indicated (2 experiments). (D) As in (C), except for the control conditions which correspond to 293T cells not expressing the siRNAs. MIC:
intracellular M; MOUT: M in the culture medium.
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directly analyzed (Fig. 7C). Fig. 7A, rSeV-ΔCs-GFP/C and
rSeV-M-gfpt lanes, shows the effect of α-GFP-siRNAs on,
respectively, the GFP/C and the M levels (compare −/+ lanes).
Note the absence of the C protein bands in the rSeV-ΔCs-GFP/
C lanes, replaced by the GFP/Cs. Note as well the equivalent
amounts of P detected which support the similar extent of
infections of both viruses in both cell lines (compare rSeV-M-
gfpt and rSeV-ΔCs-GFP/C, −/+ lanes). This point can be better
made in Fig. 7B, in which the intracellular amounts of 35S-
labeled P, HN, F0 and N proteins are shown. Despite the overlap
of N and F0 of the rSeV-ΔCs-GFP/C virus (the N protein is of
different origin in the two viruses, Garcin et al., 1998), it is
apparent that the extent of the infections in the ±α-GFP-siRNA
expressing cell lines is equivalent (if anything the infection in
the control cell line is a little higher). Panel C shows the virus
particles produced. As expected from the M central role in virus
particle formation, M suppression drastically decreased virus
particle production (compare lanes 3 and 4, see also panel D, for
quantification). On the other hand, GFP/C suppression led to no
significant change in virus particle production. If anything, a
slight increase can be observed which parallels the slight
decrease of the intracellular virus proteins (compare lanes 5 and6). Therefore a reduction in more than 70% the C protein did not
affect SeV particle production (Fig. 7E, for quantification). The
infectivity of the produced particles paralleled their physical
production (0.5±0.2×106 and 1.2±0.0×106, for respectively
the control and the α-siGFP conditions). In conclusion, this
experiment does not support an essential participation of C in
SeV particle production, unless the remaining 30% of GFP/C is
sufficient to provide a full C function.
Discussion
In this study we concentrated our efforts on examining
the cellular parameters described before as participating in
the formation and budding of SeV particles, i.e. the Alix
and the VPS4A proteins, both partners of the MVB sorting
machinery. Our experimental approach and tools have not
been different from those used in the field with the
exception of cell lines constitutively expressing si-RNAs to
suppress the Alix and the GFP/C proteins. We have also
been focusing almost exclusively on the virus particle
production resulting from regular viral infections. The data
we obtained could not confirm the conclusions reached
before concerning the involvement of the MVB machinery.
Fig. 6. Effect of VPS4A expression on SV5 and SeV budding. 293T cells in
35 mm-diameter dishes were transfected with 2 μg of pVPS4A-wt, pVPS4A-
E228Q or pVPS4A-K173Q. Six hours after transfection, cells were infected with
SV5 (A) or SeV (B) at an m.o.i. of 1 and radiolabeled from 16 h to 40 h pi.
Culture medium and cells were harvested at 40 h pi. Cell extracts were prepared
and the virus particles present in the supernatants were isolated as described in
Materials and methods. Forty micrograms of cell extract proteins was used for
detecting the VPS4A proteins by Western blot. The remaining fractions of the
cell extracts were used to immune precipitate SV5 or SeV HN and NP and 1/
10th of the total IP was analyzed by SDS-PAGE. About 1/6th (fraction adjusted
to the total protein amount in cell extracts) of the virus particle samples (VP)
were analyzed by SDS-PAGE. The radioactive gels were treated for
autoradiography. (C and D) The bands of viral proteins in virus particles were
quantified. Budding efficiency (relative total VP proteins) was calculated as the
sum of the signals corresponding to the virus proteins and expressed relative to
the control conditions (no VPS4A transfection) normalized to 1. Standard
deviations from the mean are indicated [SV5 (C), SeV (D), 2 and 3 experiments,
respectively].
Table 4
Effect of VPS4A proteins expression on SV5 infectious particle production
Virus VPS4A pfu at 40 h pi
SV5 +wt 4.5×105
+E228Q 1.5×105
+K173Q 1.4×105
293T cells in 35 mm-diameter dishes were transfected with 2 μg of pVPS4A-wt,
pVPS4A-E228Q or pVPS4A-K173Q. Six hours after transfection, cells were
infected with SV5 (m.o.i. of 1). Viral titers as described in Materials and
methods.
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the viral C protein in the process.
Alix suppression was performed using cell lines generated
by a lentivirus vector expressing the α-Alix-siRNAs along with
the GFP protein. GFP expression allowed selection and
enrichment of the transduced cells. It also constituted a mean
to evaluate the percentage of cells expressing the siRNAs at the
time of the experiment. In our experiments, more than 95% of
the cells were GFP positive, a feature that allowed us to get
around the problem raised by a too low percentage of cells
harboring suppression (as upon siRNA transfection) in front of
100% of infected cells. When we used the same approach to
suppress the viral M protein, suppression was efficient enough
to lower virus particle production by more than 50-folds
(Gosselin-Grenet et al., 2006; Mottet-Osman et al., 2007). It isthen under similar conditions of effective Alix suppression (as
also attested by Western blot analysis, Figs. 2A and E) that we
were not able to demonstrate a significant effect of this
suppression on SeV particle production.
The effects of DN-VPS4A overexpression could not be
evaluated under such optimal conditions. However, because the
VPS4A proteins were fused to GFP, we could estimate the
percentage of cells expressing these proteins by UV micro-
scopy. We then only took into account the experiments in which
more than 65% of the cells exhibited GFP fluorescence and
therefore expressed the VPS4A proteins. Also, Western blots
came to confirm the efficient expression of these proteins.
Finally, we showed that interdicting with VPS4A function
resulted in a decrease of SV5 particle production upon a regular
virus infection, reproducing previously published data (Schmitt
et al., 2005). This success came as a validation of our
experiments since lack of demonstrated effects could not
necessarily mean lack of effects. It is noteworthy, to mention at
this point, that the VPS4A proteins were not incorporated in
SeV particles as they were in SV5's, alluding to a dissimilar
implication of these proteins between the two infections.
Interaction of C and Alix has been convincingly demon-
strated by co-immune precipitation and by double hybrid
interaction assays (Sakaguchi et al., 2005; Irie et al., 2007). This
interaction has been shown to involve amino acids 212–357 of
Alix (868 aa), and the last 10 amino acids of C. This interaction
has received support in our experiments by the demonstrated
ability of C to re-localize Alix at the plasma membrane
(Dominique Garcin, not shown). The involvement of C in SeV
budding, in relation with its association with Alix, however,
remains a question of debate. As mentioned, the C proteins
exert different actions during SeV infections, and this spectrum
of effects complicates the interpretation of the C knocking out
mutants. In our hands, suppression of more than 70% of C
(GFP/C), failed to show a deficit in SeV particle production, and
in virus particle infectivity, in contrast to what had been
observed before (Kurotani et al., 1998; Latorre et al., 1998).
Either, in our experiments, the remaining C can fully provide
the C budding function, or the impairment of infectious SeV
particle production observed before resulted from a deleterious
effect of the IFN system, from a deregulation of viral RNA
synthesis or from an unknown feature selected in the process of
rescuing a poorly viable virus.
The recent observation that M interacts with Alix (Irie et al.,
2007) introduces another level of complexity in understanding
Fig. 7. Requirement for the C protein in SeV budding. A549-LV-siGFP or A549-LV-ctrl cells in 35 mm-diameter dishes were infected with rSeV-M-gfpt or rSeV-
Δ4Cs-GFP/C (m.o.i. of 2), and radiolabeled from 16 h to 40 h pi. Culture medium and cells were harvested at 40 h pi. Cell extracts were prepared and the virus particles
present in the supernatants were isolated as described in Materials and methods. Forty micrograms of the cell extracts were used for Western blotting analysis using α-
GFP, α-SeV PCVand α-M antibodies (A) and the remaining fraction of cell extracts was used for immune precipitation using an anti-SeV rabbit serum (LIIIAb) (B).
About 1/6th (adjusted to the total protein amount in the cell extracts) of the virus particles (C) were analyzed by SDS-PAGE. The radioactive gels (B and C) were
treated for autoradiography. (D) M suppression: the bands of SeV-M in cell extracts were quantified and expressed relative to the values obtained in control cells
normalized to 1. VP production: the bands of viral proteins in virus particles were quantified, summed up and expressed relative to the control conditions (no siRNA)
normalized to 1. Standard deviations from the mean are indicated (4 experiments). (E) As in D except for GFP/C (4 experiments).
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relevance of this interaction, reported to take place via a
proposed YLDL domain, remains, however, to be shown. On
the one hand, co-expression of M and wt Alix did not increase
M shedding, and, on the other hand, of the two Alix deleted
mutants that exhibited a negative effect on M shedding, one was
shown not to interact with M. Furthermore, YLDL could not be
replaced by other known late domains, so that it is not clear
whether YLDL constitutes a newly described late domain, or
whether the YLDL mutations annihilate M function in general,
a fact that would not necessarily link this interaction to the
MVB machinery recruitment. This latter possibility fits with our
failure to show that M shedding was not affected by DN-
VPS4A expression or Alix suppression (Fig. 5).
In the end, we have no clear explanation for the
discrepancies between our conclusions and the one drawn
mainly on the mechanism of SeV VLP production. It is possible
that VLP production represents a more appropriate experi-
mental system to unravel the details of virus particle formation.
It is equally possible that complete virus particle formation in
the course of an infection follows different paths. As for the C–
Alix interaction, this may concern other cellular mechanisms in
which both partners are known to be involved, like IFN
interdiction for C or apoptosis triggering for Alix (Odorizzi,
2006). In that respect, it is relevant to mention that the deletionof the 10 C-ter amino acids of the C protein, known to break the
C/Alix complex (Sakaguchi et al., 2005), destroyed the C ability
to interdict with the IFN system (Dominique Garcin, not
shown). As for the M–Alix interaction, it may be relevant that
both partners are known to interact with actin in processes that
are related to cytoskeleton remodeling and/or formation of the
bud (Giuffre et al., 1982; Pan et al., 2006). Whether this
represents a “ménage à trois” with a purpose different from the
recruitment of the MVB machinery is open to question. At this
point we acknowledge the need for further studies to be able to
get a clearer picture of the SeV particle formation and of the
respective role of the C–Alix or M–Alix interactions in this
process.
Materials and methods
Cells
All cells were grown at 37 °C under 5% CO2 atmosphere.
HeLa, LLC-MK2 and A549 cells were grown in Dulbecco
modified Eagle's medium (DMEM) supplemented with 5%
fetal calf serum (FCS). FTGH, 293T (human renal epithelial
cells expressing the simian virus 40 large T antigen) and Vero
cells were grown in Dulbecco modified Eagle's medium
(DMEM) supplemented with 10% FCS. The preparation of
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(Mottet-Osman et al., 2007). In brief, A549 cells were
transduced with a lentiviral vector expressing siRNAs targeted
to a defined sequence (gfpt) of the green fluorescent protein
(GFP) gene and expressing the nerve growth factor receptor
(NGFR) as described in (Wiznerowicz and Trono, 2003). The
A549-LV-ctrl cell lines were transduced with a lentiviral vector
expressing the NGFR alone. The transduced cells were selected
on the basis of efficient NGFR surface expression. The FTGH-
α-Alix-siRNA and 293T-α-Alix-siRNA cell lines were gener-
ated with the same technology. FTGH and 293T cells were
transduced with a lentiviral vector expressing the GFP and
siRNAs targeted to a defined sequence of the Alix gene (5′-
GAGCTGTGTGTTGTTCAATT-3′). The FTGH-ctrl and 293T-
ctrl cell lines were transduced with a lentiviral vector expressing
the GFP alone. The transduced cells were selected on the basis
of efficient GFP expression.
Antibodies
Antibodies used in this study include a rabbit serum raised
against all the SeV proteins (LIIIAb), anti-SeV HN (a rabbit
serum raised against SDS-denatured HN protein, α-HNSDS),
anti-SeV N (a rabbit serum raised against SDS-denatured N
protein, α-NSDS), anti-SeV M (MAb 383 obtained from Claes
Örvell (Laboratory of Clinical Virology, Huddinge Hospital,
Huddinge, Sweden), anti-SeV PCV (a rabbit serum raised
against P, C and V proteins, α-PCV), anti-Influenza virus HA
epitope MAb (16b12, Covance Research Products Inc.) and
anti-GFP (a rabbit polyclonal serum raised against the full-
length GFP protein, BD Living Colors Antibodies, Clontech
Laboratories). The anti-Alix antibody was a gift from Gisou
van der Goot (EPFL, Lausanne, Switzerland). The antibodies
raised against SV5-HN, -NP and -M proteins were a gift from
Randall RE (University of St. Andrews, Scotland, United
Kingdom). Peroxidase-coupled secondary antibodies were
from BioRad.
Plasmids
The plasmids encoding GFP-VPS4A and dominant negative
mutants VPS4A-E228Q and VPS4A-K173Q were kindly
provided by Robert A. Lamb (Northwestern University,
Evanston, USA). The pEBS-HA-M plasmid was prepared
from pEBS-GFP (Mottet-Osman et al., 2007) by replacement of
the GFP gene with that of the HA tagged M (Mottet et al.,
1996).
Viruses
Sendai virus was prepared and characterized as before (Roux
and Holland, 1979). rSeV-M-gfpt is a recombinant SeV
harboring in its M gene 5′ untranslated region a sequence
derived from the GFP gene (5-AAGAACGGCAUCAAGGU-
GAACUUAGC-3). Detailed description of the preparation of
this rSeV is done in details elsewhere (Mottet-Osman et al.,
2007). rSeV-Δ4C-GFP/C was constructed by Machiko Nishiowhile on sabbatical leave in Daniel Kolakofsky laboratory
(University of Geneva, Switzerland). This rSeV does not
express C proteins by introduction of 3 stop codons in the open
reading frame of Y2, but expresses a GFP-fused C protein from
a supplementary transcription unit inserted between the F and
the M genes. SV5 (WR strain) was a kind gift from Machiko
Nishio (Mie University Graduate School of Medicine, Japan)
and was propagated on Vero cells.
Virus infections and radiolabeling
Infections with Sendai virus (SeV), its various recombinants
(rSeV) or SV5 were performed at 33 °C. Virus stocks were
adequately diluted (multiplicity of infection indicated in the
figure legends) in DMEM without FCS and laid over the cells
for 1 h. At the end of the infection period, the infectious mix was
removed and replaced with fresh DMEM supplemented with
2% FCS. For radiolabeling, cells were incubated with 20 μCi of
L-35S-methionine and L-35S-cysteine (Pro-mix-[35S] in vitro
cell labeling mix, Amersham Biosciences) in DMEM contain-
ing 1/10th the normal methionine and cysteine content plus
0.2% FCS, from 16 to 40 h pi. In the other cases, the medium
was replaced at 16 h pi. by fresh medium containing 2% FCS.
Culture medium and cells were harvested at the time indicated
in the figure legends and analyzed as described below.
Transfections
HeLa cells in 35 mm-diameter dishes were transfected with
20 μM of anti-Alix siRNA (target sequence: 5′-AAGCCGC-
TGGTGAAGTTCATC-3′, from Qiagen) using Oligofectamine
(Invitrogen) according to the manufacturer's instructions, 48 h
before SeV infection. 293T cells in 35 mm-diameter dishes were
transfected with 2 μg of pVPS4A-wt, pVPS4A-E228Q or
pVPS4A-K173Q using the FuGENE 6 transfection reagent
(Roche) according to the manufacturer's instructions, 6 h before
infection, or 16 h previous to pEBS-HA-M transfection.
Cellular extracts and immunoprecipitations
Transfected or infected cells were collected and disrupted in
300 μl of Lysing Buffer II (150 mM NaCl, 1% deoxycholate,
1% triton X-100, 0.1% sodium dodecyl sulfate, 10 mM Tris–
HCl, pH 7.4) containing 1% aprotinin and 20 mM AEBSF as
described before (Mottet et al., 1986). After 10 s of sonication
(Branson Sonic Sonifer B-12, lowest speed), cell extracts were
spun for 10 min at 12000 rpm in a microfuge. The supernatants
were then processed for Western blotting analysis or IP. IP was
performed as described before (Mottet et al., 1986). The total
cellular extracts were first incubated with the specific antisera
overnight at 4 °C, then with 50% suspension of protein A-
sepharose 2 h at 4 °C to recover the immune complexes.
Virus particle or M-VLPs isolation
The virus particles or the M-VLPs were isolated from the
clarified cell supernatants by centrifugation through a 25%
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and directly resuspended in SDS sample buffer.
SDS-PAGE analyses, Western blotting, autoradiography and
quantification
The total cellular extracts and the virus particles or the M-
containing vesicles were analyzed by SDS-PAGE. After
electrophoresis, the proteins were transferred using a semi-dry
system onto polyvinylidene difluoride membranes (Millipore).
Blots were then incubated with specific antibodies, followed by
the appropriate horseradish peroxidase (HRP)-coupled second-
ary antibodies. Protein detection was performed by using the
enhanced chemiluminescence system (Amersham Biosciences).
The radiolabeled virus particle samples and the total IP samples
were analyzed by SDS-PAGE and the gels, treated for enhanced
fluorography (DMSO plus 5% PPO), were exposed to
Hyperfilm MP (Amersham Biosciences). The films were
scanned and the band signals were quantified with ImageQuant
TL software (Amersham Biosciences).
Virus titration
Culture mediums from SeV-infected cells were collected and
previously treated 30 min at 37 °C with 1.5 μg/ml of acetylated
trypsin. SeV titers were determined by plaquing on LLC-MK2
cells under a 0.3% agarose overlay in the presence of 1.5 μg/ml
of acetylated trypsin according to Sugita et al. (1974). SV5 titers
were determined by plaquing on Vero cells under a 0.5% agar
overlay.
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